1. BiTE antibody/immunotherapy: MITI, CLDX 2. Generic/biosimilar/biobetter: PLX, MNTA 3. Ultrafast insulin: HALO, BIOD 4. Small molecule kinase inhibitor: ARRY, PCYC, EXEL 5. Antibody conjugate: IMGN, SGEN 5. Drug delivery/modification of existing drug: NKTR, HALO 6. Established small/mid cap: BMRN, ONXX I should add, in Antiviral/antibacterial space, I like VRTX. However, VRTX is almost big cap now, which is why I didn't list it. I haven't found small to mid cap I really like in this space yet.